TITAN Bundle
The TITAN Bundle is a four-vial research stack spanning two research axes: Grow-H 10 mg (CJC-1295 no DAC + Ipamorelin), Ipamorelin 10 mg, BPC-157 10 mg and TB-500 5 mg — at 10% off the individual vial prices.
On the growth-hormone axis, the long-acting form of CJC-1295 produced prolonged GH and IGF-I elevations in healthy adults[1], while Ipamorelin is the first selective growth-hormone secretagogue described in the literature[3]. On the repair axis, BPC-157 was studied in tendon-healing models[5] and TB-500 is synthetic full-length thymosin beta-4, an actin-regulating peptide that promoted cell migration and repair signalling in preclinical studies[8].
Each vial is supplied as a lyophilized powder for reconstitution, and each compound has its own lot-specific third-party certificate of analysis, available on request. Findings above come from preclinical and early-phase clinical research on these molecules and are provided as scientific reference for laboratory research only.
Couldn't load pickup availability
Out of stock — get notified
Leave your email and we’ll let you know the moment it’s available again.
Need reconstitution solution? Don’t forget to add Bacteriostatic Water before checkout.
Four-Vial Research Stack
Four Vials, Two Research Axes
The TITAN Bundle covers two distinct research axes in a single four-vial stack. On the growth-hormone axis, Grow-H pairs CJC-1295 (no DAC), a GHRH(1-29) analogue — the long-acting form of CJC-1295 produced prolonged GH and IGF-I elevations in healthy adults[1] — with Ipamorelin, the first selective growth-hormone secretagogue described in the literature[3]. On the tissue-repair axis, BPC-157 has been documented in tendon-healing models[5] and in angiogenesis models, with pro-angiogenic activity associated with VEGFR2 activation[9], while TB-500 is synthetic full-length thymosin beta-4, a principal G-actin-sequestering peptide[7].
- Two research axes: GH-axis signalling + tissue repair
- Grow-H — CJC-1295 (no DAC) and Ipamorelin in one vial
- BPC-157 — tendon-healing and angiogenesis models
- TB-500 — full-length thymosin beta-4 (43 aa)
- Lot-specific third-party COA for each compound
Inside the Bundle
What's in the Stack
The bundle ships as four separate lyophilized vials: Grow-H 10 mg (CJC-1295 no DAC + Ipamorelin), Ipamorelin 10 mg, BPC-157 10 mg and TB-500 5 mg. The design is deliberate: the GHRH analogue and the secretagogue act on two different pituitary receptor systems — in clinical studies, pulsatile GH secretion persisted during continuous stimulation by long-acting CJC-1295[2] — while BPC-157 and TB-500 have been studied separately on local repair pathways such as fibroblast migration[5] and actin dynamics[7].
- Grow-H — 10 mg combination vial (CJC-1295 no DAC + Ipamorelin)
- Ipamorelin — 10 mg lyophilized vial
- BPC-157 — 10 mg lyophilized vial
- TB-500 — 5 mg lyophilized vial
- 10% saving versus buying the four vials separately
Research Applications
Areas of Scientific Investigation
Each compound carries its own line of preclinical or early-phase evidence: BPC-157 accelerated healing of the transected Achilles tendon in a rat model[6], thymosin beta-4 — the molecule supplied as TB-500 — activated integrin-linked kinase and promoted cardiac cell migration and survival[8], and Ipamorelin's pharmacokinetics were modelled in human volunteers[4]. No published study evaluates the four compounds in combination; researchers using them side by side are combining independent lines of evidence.
- Growth-hormone axis and pituitary signalling studies
- Tendon, ligament and muscle injury models
- Wound-healing and angiogenesis assays
- Actin dynamics and cytoskeletal research
Understanding the Titan Stack: Mechanism of Action
The growth-hormone side of the stack works through two complementary receptor systems. CJC-1295 (no DAC), the GHRH(1-29) analogue in Grow-H, targets pituitary GHRH receptors: in healthy adults, the long-acting form of CJC-1295 produced prolonged elevations of GH and IGF-I[1], and pulsatile GH secretion persisted during continuous stimulation[2]. Ipamorelin — present both inside Grow-H and as its own 10 mg vial — is a pentapeptide described as the first selective growth-hormone secretagogue: in animal models it stimulated GH release via the GHRP (ghrelin) receptor without meaningfully raising cortisol or ACTH[3], and its pharmacokinetics have been modelled in human volunteers[4].
The repair side pairs two extensively studied molecules. BPC-157, a 15-amino-acid fragment of the Body Protection Compound found in gastric juice, promoted tendon-fibroblast outgrowth and migration, likely via the FAK–paxillin pathway[5] and accelerated healing of transected tendon in a rat study[6]. TB-500 is synthetic full-length thymosin beta-4 (43 amino acids), identified as a principal G-actin-sequestering peptide[7]; in a 2004 Nature study, thymosin beta-4 activated integrin-linked kinase and promoted cardiac cell migration and survival after injury[8].
Together, the four vials give researchers a two-axis model: pituitary GH-axis signalling probed through two independent receptor systems, alongside local tissue-repair pathways — angiogenic and cytoprotective signalling (BPC-157) and actin regulation (TB-500). Each pathway is supported by its own line of evidence; no published study evaluates the combination itself. These materials are supplied strictly for laboratory research use.
Scientific Literature
- Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805.
- Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006;91(12):4792-4797.
- Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-61.
- Gobburu JV, Agerso H, Jusko WJ, Ynddal L. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res. 1999;16(9):1412-6.
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011;110(3):774-80.
- Staresinic M, Sebecic B, Patrlj L, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-83.
- Safer D, Elzinga M, Nachmias VT. Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem. 1991;266(7):4029-32.
- Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432(7016):466-72.
- Hsieh MJ, Liu HT, Wang CN, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017;95(3):323-333.
Packaged with care, shipped fast.
We’re a passionate team obsessed with quality, not margins.
- Company
- Price
- Purity
- Quantity
- Shipping
-
TITAN Bundle
-
Prime
Lab PeptidesTypical
Competitor -
$252.00$455.00
- ≥99%96%
- 4 vials4 vials
- Free 2-Day Shipping3-10 Business Day
-
